Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6352266rdf:typepubmed:Citationlld:pubmed
pubmed-article:6352266lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6352266lifeskim:mentionsumls-concept:C0032173lld:lifeskim
pubmed-article:6352266lifeskim:mentionsumls-concept:C0000946lld:lifeskim
pubmed-article:6352266lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6352266lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:6352266lifeskim:mentionsumls-concept:C0599756lld:lifeskim
pubmed-article:6352266lifeskim:mentionsumls-concept:C0857121lld:lifeskim
pubmed-article:6352266pubmed:issue5lld:pubmed
pubmed-article:6352266pubmed:dateCreated1983-11-23lld:pubmed
pubmed-article:6352266pubmed:abstractTextIn 12 patients with arterial hypertension (stages I and II according to WHO), adrenergic stimulation was induced by the immersion of a hand in ice water for 2 min. Blood samples were withdrawn before, at the end of, and 15 min after the cold application: the experiment was repeated 2 h after the ingestion of 200 mg acebutolol, a selective betablocking agent. The following assays were performed: serum nonesterified fatty acid (NEFA), plasma beta-thromboglobulin (BTG) and PF4 with specific radioimmunoassays; thromboxane B2 (TXB2) in plasma was also estimated with radioimmunoassay, platelet sensitivity to exogenous prostacyclin; furthermore, the thrombin-induced thromboxane production before and after acebutolol ingestion as well as serum TXB2-levels were measured. The blood pressure and the heart rate were also monitored. After cold stimulation, a significant increase of NEFA, BTG, and plasma TXB2 was observed, which was still discernible 15 min after the application of cold. After acebutolol, the cold treatment led to a lower increase of blood pressure with a reduction of the heart rate, as well as to a diminished release of BTG, PF4 and TXB2 no changes in the reduced platelet sensitivity to prostacyclin were noticed.lld:pubmed
pubmed-article:6352266pubmed:languageenglld:pubmed
pubmed-article:6352266pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6352266pubmed:citationSubsetIMlld:pubmed
pubmed-article:6352266pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6352266pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6352266pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6352266pubmed:statusMEDLINElld:pubmed
pubmed-article:6352266pubmed:monthMaylld:pubmed
pubmed-article:6352266pubmed:issn0195-668Xlld:pubmed
pubmed-article:6352266pubmed:authorpubmed-author:StranoAAlld:pubmed
pubmed-article:6352266pubmed:authorpubmed-author:NovoSSlld:pubmed
pubmed-article:6352266pubmed:authorpubmed-author:CustroNNlld:pubmed
pubmed-article:6352266pubmed:authorpubmed-author:PintoAAlld:pubmed
pubmed-article:6352266pubmed:authorpubmed-author:AvernaMMlld:pubmed
pubmed-article:6352266pubmed:authorpubmed-author:MattinaAAlld:pubmed
pubmed-article:6352266pubmed:authorpubmed-author:Davi'GGlld:pubmed
pubmed-article:6352266pubmed:issnTypePrintlld:pubmed
pubmed-article:6352266pubmed:volume4lld:pubmed
pubmed-article:6352266pubmed:ownerNLMlld:pubmed
pubmed-article:6352266pubmed:authorsCompleteYlld:pubmed
pubmed-article:6352266pubmed:pagination295-9lld:pubmed
pubmed-article:6352266pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:6352266pubmed:meshHeadingpubmed-meshheading:6352266-...lld:pubmed
pubmed-article:6352266pubmed:meshHeadingpubmed-meshheading:6352266-...lld:pubmed
pubmed-article:6352266pubmed:meshHeadingpubmed-meshheading:6352266-...lld:pubmed
pubmed-article:6352266pubmed:meshHeadingpubmed-meshheading:6352266-...lld:pubmed
pubmed-article:6352266pubmed:meshHeadingpubmed-meshheading:6352266-...lld:pubmed
pubmed-article:6352266pubmed:meshHeadingpubmed-meshheading:6352266-...lld:pubmed
pubmed-article:6352266pubmed:meshHeadingpubmed-meshheading:6352266-...lld:pubmed
pubmed-article:6352266pubmed:meshHeadingpubmed-meshheading:6352266-...lld:pubmed
pubmed-article:6352266pubmed:meshHeadingpubmed-meshheading:6352266-...lld:pubmed
pubmed-article:6352266pubmed:meshHeadingpubmed-meshheading:6352266-...lld:pubmed
pubmed-article:6352266pubmed:meshHeadingpubmed-meshheading:6352266-...lld:pubmed
pubmed-article:6352266pubmed:meshHeadingpubmed-meshheading:6352266-...lld:pubmed
pubmed-article:6352266pubmed:meshHeadingpubmed-meshheading:6352266-...lld:pubmed
pubmed-article:6352266pubmed:year1983lld:pubmed
pubmed-article:6352266pubmed:articleTitlePlatelet activation after adrenergic stimulation in hypertensive patients: effects of acebutolol.lld:pubmed
pubmed-article:6352266pubmed:publicationTypeJournal Articlelld:pubmed